|
Invited Speakers:
|
|
Tejdip Singh, M.D., Medical Director, Global Patient Safety and Risk Management, Genzyme Corporation, USA Laura Sepp-Lorenzino, Ph.D., Senior Director, RNA Therapeutics, Merck & Co., Inc., USA Nozer Mehta, Ph.D., Vice President, R&D, UniGene Laboratories, Inc., USA Yuji Heike, M.D., Ph.D., Hemato-Oncology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Japan Arthur A. Levin, Ph.D., Chief Development Officer, Santaris A/S, USA and Denmark
AND MANY MORE!
|
|